Organometallics
Article
NMR: Not possible due to poor solubility of the pure compound in
Ph), 153.5 (dd, 2JCP = 15.3 Hz, J = 3.1 Hz, Pos. 5). P NMR (162
2
31
31
1
2
2
deuterated solvent. P{ H} NMR (162.1 MHz, THF-d ): δ [ppm] =
MHz, THF-d ) δ = 24.8 (d, J = 61.3 Hz, PCy ), 55.53 (d, J
=
8
8
PP
2
PP
2
2
−1
1
3.11 (dd, J = 44.9, 34.2 Hz PCy ), 50.7 (dd, J = 45.0, 34.2 Hz,
PCS). IR (ATR) [cm ]: 2914 (m), 2843 (m), 1441 (m), 1257 (w),
60.9 Hz, PCS). IR (ATR) [cm ]: 2918 (m), 1442 (m), 1107 (m),
1059 (s), 872 (m), 741 (s), 688 (s), 657 (w), 513 (w), 458 (m), 411
(m). CHNS for C H ClP PdS: Calcd: C: 58.87, H: 7.12, S: 4.62.
PP
2
PP
−
1
1
7
109 (m), 1058 (s), 1000 (w), 887 (m), 868 (s), 851 (w), 741 (s),
12 (m), 366 (m), 543 (w), 514 (m), 471 (m), 441 (m), 406 (m).
3
4
49
2
Measured: C: 59.18, H: 7.22, S: 4.39. Melting point: 115.2 °C
CHNS for C H P PdS : Calcd: C: 61.56, H: 8.27, S: 6.57.
(decomposition).
50
80
4
2
Measured: C: 61.88, H: 7.87, S: 6.49. Melting point: 195.8 °C
Synthesis of Pd 1. First, 250 mg (0.58 mmol) of L1 and 178 mg
in
t
(
decomposition).
of [Pd( Bu-Indenyl)Cl] (33.2 m% Pd, 0.29 mmol) were suspended
2
Synthesis of Pd 1. 250 mg (0.58 mmol) of L1 and 108 mg of
in 10 mL of pentane and stirred for 2 h. The dark gray suspension
al
[
Pd(allyl)Cl] (56.4 m% Pd, 0.29 mmol) were suspended in 10 mL of
formed was filtered, and the solid was washed (2 × 5 mL) with
2
pentane and stirred for 30 min. A yellow suspension formed, which
pentane. Complex Pd 1 was obtained as a gray solid in 84.2% yield
in
was filtered, and the remaining solid was washed (2 × 5 mL) with
(352 mg, 0.47 mmol). By slow diffusion of pentane into a solution of
Pd 1 in C D , crystals suitable for single-crystal XRD could be
pentane. Complex Pd 1was obtained as a yellow solid in 74% yield
al
in
6
6
1
(
255 mg, 0.56 mmol). By slow diffusion of pentane into a solution of
obtained. H NMR (400 MHz, C D ): δ [ppm] = 0.84−0.98 (m, 4H,
6
6
Pd 1in C D crystals of a decomposition product suitable for single-
crystal XRD could be obtained. H NMR (400 MHz, C D ): δ [ppm]
iPr CH ), 1.02−1.13 (m, 6H, iPr CH ), 1.18 (m, 2H, iPr CH ), 1.22−
al
6
6
3
3
3
1
t
1.88 (m, 18H, PCy CH H
), 1.68 (s, 9H, Bu CH ), 2.21 (m,
2+3+4 3
6
6
2
2
=
0.88−1.10 (m, 6H, iPr CH ), 1.10−1.29 (m, 8H, iPr CH , PCy
3H, PCy CH H
), 2.42 (m, 1H, PCy CH H
), 2.60 (dqd,
2+3+4
3
3
2
2
2
2+3+4
2
2
3
2
CH H
), 1.30−1.92 (m, 13H, PCy CH H
), 2.21−2.31 (d,
2H, J = 3.17, 9.35, 9.47, 12.1 Hz, PCy CH H ), 3.55 (dp, 1H, J
=
=
2
2+3+4
2
2
2+3+4
2
1
PH
3
3
3
2
2
H, J = 12.5 Hz, PCy CH H
), 2.32 (d, 2H, J = 11.2 Hz, Allyl
14.2 Hz, J = 7.2, 7.2, 7.24, 7.24 Hz, iPr CH), 4.18 (dp, 1H, J
2
2
2+3+4
PH
3
3
2
CH H ), 2.38−2.53 (dt, 2H, J = 9.0, 9.0, 22.2 Hz, PCy CH
H
14.2 Hz, J = 7.2, 7.2, 7.24, 7.24 Hz, iPr CH), 5.43 (dd, 1H, J = 1.37,
2
5
2
2
3
2
), 2.53−2.71 (p, 2H, J = 15.1, 15.1, 17.1, 17.1 Hz, PCy CH
2.89 Hz, Ind), 6.32 (dd, 1H, J = 0.92, 2.93 Hz, CH, Ind), 6.71 (m,
1H, CH Pos. 4), 6.79 (m, 1H, CH, Ind), 6.85 (m, 1H, CH Pos. 2),
6.93 (m, 1H, CH, Ind), 7.03 (m, 2H, CH Pos 1 + Ind), 7.19 (m, 1H,
2
+3+4
2
2
3
H ), 3.47 (dd, 1H, J = 8.7, 13.8 Hz, Allyl CH H ), 5.53 (m, 1H, Allyl
CH H ), 3.6 (dp, 1H, J = 5.24, 5.24, 5.25, 5.25 Hz, J = 14.2 Hz,
iPr CH), 3.74 (dp, 1H, J = 7.04, 7.04, 7.05, 7.05 Hz, J = 14.2 Hz,
1
2
2
3
2
2
4
HP
3
2
13
1
CH Pos 3), 7.47 (m, 1H, CH, Ind). C{ H} NMR (101 MHz, C D )
HP
6 6
3
2
2
iPr CH), 4.52 (t, 1H, J = 7.19, 7.19 Hz, Allyl CH H ), 4.89 (ddd, 1H,
δ = 7.24 (dd, J = 106.6, 42.8 Hz, PCS), 17.9 (d, J = 1.9 Hz, iPr
3
3
2
2
J = 7.96, 13.7, 17.9 Hz, Allyl CH H ), 6.83−6.91 (m, 1H, CH Pos.
CH ), 18.1 (d, J = 2.2 Hz, iPr CH ), 18.2 (d, J = 2.1 Hz, iPr CH ),
1
3
3
3
2
2
4
7
), 6.83−6.91 (m, 1H, CH Pos. 2), 7.01−7.12 (m, 1H, CH Pos. 1),
18.6 (d, J = 2.2 Hz, iPr CH ), 26.5 (d, J = 20.5 Hz, CH PCy
3 2 2
1
3
1
2
2
.13−7.23 (m, 1H, CH Pos. 3). C{ H} NMR (101 MHz, C D ) δ
C2+3+4), 27.2 (dd, J = 12.0, 4.0 Hz, CH PCy C
), 27.7 (dd, J =
6
6
2
2
2+3+4
1
[
ppm] = 6.01 (dd, J = 37.9, 106.5 Hz, PCS), 18.1 (d, J = 2.2 Hz,
15.0, 12.9 Hz, CH PCy C
), 29.1 (s, CH PCy C2+3+4), 29.5 (s,
CP
2
2
2+3+4 2 2
2
t
t
2
iPr CH ), 26.9 (s, CH PCy C
C2+3+4), 28.1 (d, J = 12.6 Hz, CH PCy C
C2 ), 30.1 (s, CH PCy C
), 27.7 (d, J = 12.1 Hz, CH PCy
Bu C(CH ) ), 29.5 (s, Bu C(CH ) ), 29.8 (d, J = 41.8 Hz, CH Ind),
3
2
2
2+3+4
2
2
3 3 3 3
2
2
2
t
), 30.0 (s, CH PCy
31.0 (d, J = 47.0 Hz, CH Ind), 34.6 (d, J = 4.5 Hz, Bu C(CH ) ),
3 3
41.2 (dd, J = 52.2 Hz, J = 26.6 Hz, CH PCy C ), 64.8 (d, J = 3.5
2
2
2+3+4
2
2
1
2
2
), 30.4(s, CH PCy C
), 30.6
+3+4
2
2
2+3+4
2
2
2+3+4
CP 2 1
1
1
2
2
1
(
d, J = 6.5 Hz, iPr CH(CH ) ), 40.4 (dd, J = 74.1 Hz, J = 26.7
Hz, CH Ind), 107.9 (d, J = 5.8 Hz, CH Ind), 117.8 (dd, J = 88.9
CP
3
2
CP
CP
2
2
2
Hz, CH PCy C ), 50.7 (d, J = 2.3 Hz, CH allyl), 79.6 (d, J = 29.1
Hz, CH allyl), 114.3 (d, J = 4.6 Hz, CH allyl), 118.0 (dd, J = 90.0
Hz, J = 5.9 Hz, Pos. 6), 122.2 (d, J = 9.2 Hz, Pos. 4), 122.9 (d, J =
Hz, J = 5.3 Hz, C Pos. 6), 118.0(s, CH Ind), 120.5 (s, CH Ind), 121.7
2
1
2
2
1
2
2
2
CP
(d, J = 9.1 Hz, CH Pos. 4), 122.4 (d, J = 6.6 Hz, CH Pos. 3), 124.71
2
2
2
2
2
2
(d, J = 63.4 Hz, CH Ind), 125.9 (d, J = 23.2 Hz, C Ind), 129.0 (d, J
2
2
2
2
6
.7 Hz, Pos. 3), 129.5 (d, J = 2.2 Hz, Pos. 2), 130.2 (d, J = 9.3 Hz,
= 2.2 Hz, CH Pos. 2), 130.4 (d, J = 9.2 Hz, CH Pos. 1), 138.7 (d, J =
2
2
31
1
3
2
Pos. 1), 152.8 (dd, J = 15.5 Hz, J = 3.1 Hz, Pos. 5). P{ H} NMR
5.4 Hz, C Ind), 140.3 (s, C Ind), 152.1 (dd, J = 14.8 Hz, J = 3.5
CP
2
31
2
(
(
1
4
7
1
162.1 MHz, C D ): δ [ppm] = 20.3 (d, J = 60.8 Hz, PCy ), 55.5
d, J = 61.1 Hz, PCS). IR (ATR) [cm ]: 2924 (m), 2845 (w),
442 (m), 1262 (w), 1106 (m), 1064 (s), 864 (m), 742 (s), 657 (m),
59 (m), 405 (w). CHNS for C H ClP PdS: Calcd: C: 54.37, H:
.50, S: 5.18. Measured: C: 54.22, H: 7.79, S: 5.18. Melting point:
Hz, C Pos. 5). P NMR (162 MHz, C D ) δ = 27.0 (d, J = 55.8
6
6
PP
2
6
6
PP
2
−1
2
−1
PP
Hz, PCy ), 56.7 (d, J = 56.0 Hz, PCS). IR (ATR) [cm ]: 2926
2
PP
(m), 2843 (w), 1444 (m), 1362 (w), 1275 (w), 1196 (s), 1104 (m),
1060 (s), 1046 (m), 873 (m), 743 (s), 687 (m), 628 (w), 511 (m),
461 (s), 426 (s). CHNS for C H ClP PdS: Calcd: C: 61.04, H:
7.66, S: 4.74. Measured: C: 61.27, H: 7.89, S: 4.49. Melting point:
155.3 °C (decomposition).
Synthesis of 9-Methyl-fluorene (9-Me-Fluorene). Following a
slightly modified literature procedure, 4.99 g (30 mmol) of fluorene
was dissolved in 60 mL of THF and cooled to −60 °C. To this was
slowly added (over a period of 15 min) 26 mL of a 1.55 M solution of
nBuLi in hexane. The solution was warmed to room temperature and
stirred for 1.5 h. The solution was cooled to −60 °C, and 2.8 mL
(6.39 mg, 45 mmol) of MeI was added slowly over 5 min. The
solution became clear and colorless and was then stirred for 15 min at
−60 °C and 2 h at room temperature. Excess MeI was quenched with
100 mL of aqueous KOH solution. The aqueous phase was separated
2
8
45
2
3
8
55
2
46.7 °C (decomposition).
Synthesis of Pd 1. First, 200 mg (0.46 mmol) of L1 and 118 mg
cin
of [Pd(Cinnamyl)Cl] (40.2 m% Pd, 0.23 mmol) were suspended in
2
27
8
mL of pentane and stirred for 2 h. A red suspension formed. This
was filtered, and the solid was washed (2 × 5 mL) with pentane.
Complex Pd 1 was obtained as a red-orange solid in 55.2% yield
cin
(
176 mg, 0.25 mmol). By slow diffusion of pentane into a solution in
1
THF-d , crystals suitable for X-ray diffraction could be obtained. H
8
NMR (400 MHz, THF-d ): δ [ppm] = 1.07−1.85 (m, 27H, iPr CH
8
3
+
PCy CH H
), 1.97−2.26 (m, 5H, PCy CH H
), 2.30−
2
2
2+3+4
2
2
2+3+4
3
2
.52 (m, 2H, PCy CH H ), 2.69−2.77 (d, 1H, J = 11.9 Hz, cin
2
1
3
CH ), 3.58 (m, 1H, iPr CH), 3.71 (m, 1H, iPr CH), 3.80 (d, 1H, J =
2
3
6
1
.7 Hz, iPr CH), 5.06 (dd, 1H, J = 13.1, 9.3 Hz, cin CH), 5.83 (m,
H, cin CHPh), 7.02−7.10 (m, 1H, Pos. 4), 7.19−7.29 (m, 4H, cin
and extracted (2 × 5 mL) with Et O. The combined organic phases
were dried with MgSO , and the solvent was removed. The crude
product was filtered over a short silica column with hexane as eluent.
2
4
CH Ph + Pos. 2), 7.31−7.37 (m, 1H, Pos. 1), 7.42−7.46 (m, 2H, cin
1
3
CH Ph), 7.49−7.55 (m, 1H, Pos.3). C NMR (101 MHz, THF-d ):
The product was obtained as a yellow waxlike solid in 91% yield (5.0
8
1
2
1
δ [ppm] = 7.2 (dd, J = 107.2, 39.1 Hz, PCS), 18.6 (d, J = 2.2
g, 27.4 mmol). H NMR (400 MHz, THF-d ): δ [ppm] = 1.44 (d,
CP
CP
8
2
3
3
Hz, iPr CH ), 18.8 (d, J = 2.0 Hz, iPr CH ), 23.4 (s, PCy CH ),
3H, J = 7.34 Hz, CH ), 3.85 (q, 1H, J = 7.30 Hz, 9HFlu), 7.26 (m,
3
27
3
CP
3
2
2
1
3
2
7.6 (s, PCy CH ), 28.0−31.3 (m, PCy CH ), 32.0 (d, J = 46.4
4H, Ar), 7.42 (d, 2H, J = 7.15 Hz, Ar), 7.67 (m, 2H, Ar).
2
2
2
2
CP
1
1
Hz, iPr CH), 40.0 (d, J = 27.2 Hz, PCy CH), 42.5 (d, J = 25.6
Synthesis of CIPCyFlu. First, 5.00 g (27.4 mmol) of 9-Me-
Fluorene was dissolved in 110 mL of THF and cooled to −60 °C.
17.7 mL of a 1.55 M solution of nBuLi in hexane was added slowly
over 15 min. The solution turned red and was stirred for 30 min at 60
°C, before being cooled and stirred for 2 h at room temperature. A
second solution of 4.2 mL (29 mmol, 5.07 g) of PCyCl in 40 mL of
THF was prepared and cooled to −60 °C. The lithiated 9-Me-
CP
2
CP
2
2
Hz, PCy CH), 48.1 (d, J = 2.6 Hz, cin CH ), 98.8 (d, J = 26.8 Hz,
2
2
2
1
cin CH), 109.6 (d, J = 5.2 Hz, cin CHPh), 118.7 (dd, J = 89.7 Hz,
CP
2
3
3
J = 5.6 Hz, Pos. 6), 123.0 (d, J = 9.2 Hz, Pos. 4), 123.4 (d, J
=
CP
CP
2
2
6
.7 Hz, Pos.2), 127.9 (d, J = 2.4 Hz, Pos. 1), 128.7 (d, J = 3.3 Hz,
CP
2
2
cin CH Ph), 129.1 (d, J = 2.0 Hz, cin CH Ph), 130.2 (d, J = 2.2 Hz,
cin CH Ph), 131.5 (d, J = 9.5 Hz, Pos. 3), 138.7 (d, J = 6.1 Hz, cin C
2
2
2
I
Organometallics XXXX, XXX, XXX−XXX